Grants

downtown revitalizationeconomic developmenthistoric preservation

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kenya National Research Fund

Kenya National Research Fund

Funds research and innovation across Kenyan universities and research institutions.

$20K – $200K

researchinnovationscience

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kering Foundation Women's Grants

Kering Foundation

Dedicated to combating violence against women; funds prevention, shelter, and economic empowerment.

$25K – $500K

women's safetyviolence preventionwomen's empowerment

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kern Family Foundation Christian Higher Education Grants

Kern Family Foundation

Supports character formation and entrepreneurial leadership in Christian colleges and universities. Major funder of CCCU schools.

$25K – $500K

Christian higher educationcharacter formationentrepreneurship

Free to search & build · $99 one-time to unlock the application pack · No subscription

Key electronic components

European Commission - EDF

Key electronic components. Call: 2nd call for proposals for industrial reinforcement actions under the Programme. Programme: EDF. Open call from the EU Funding & Tenders Portal.

$50K

2027-02-16

research

Free to search & build · $99 one-time to unlock the application pack · No subscription

KeyBank Foundation Neighbors Grants

KeyBank Foundation

Invests in affordable housing, workforce training, and financial wellness in 15 states.

$10K – $500K

Housingworkforce developmentfinancial wellness

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) requests applications for the Kidney Precision Medicine Project (KPMP) Central Hub (CH) to lead a unified effort to discover and define new acute and chronic kidney disease pathways and subgroups that enable precision clinical trials. The CH will provide strategic leadership for the entire KPMP and steward advanced computational analyses, data management and sharing, communication and outreach, and business operations to realize the vision of the KPMP. All KPMP personnel will actively participate in scientific discovery and promote open science.

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)

National Institutes of Health

Health

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)

National Institutes of Health

Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed)

National Institutes of Health

Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed)

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) requests applications for Kidney Precision Medicine Project (KPMP) Recruitment Sites (RS) to enroll people with Acute Kidney Injuries (AKI) and/or Chronic Kidney Diseases (CKD) into a longitudinal biopsy cohort study. Under-enrolled populations (e.g., AKI) and comprehensive phenotyping remain priorities. New opportunities include clinical biopsies with residual tissue for research, enhanced physiologic phenotyping, repeat biopsies, pediatric recruitment, and collection of healthy reference tissue. All KPMP personnel will actively participate in scientific discovery and promote open science.

Up to $450K

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) requests applications for Kidney Precision Medicine Project (KPMP) Tissue Interrogation Sites (TIS) to use highly integrated multi-modal analytic pipelines to interrogate human kidney biopsy tissue to discover and define new disease pathways and subgroups that enable precision clinical trials. All KPMP personnel will actively participate in scientific discovery and promote open science.

Up to $1.5M

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)

National Institutes of Health

Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning communitY - Coordinating Center (KUH-FAMILY) (U24- Clinical Trials Not Allowed)

National Institutes of Health

Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning communitY - Coordinating Center (KUH-FAMILY) (U24- Clinical Trials Not Allowed)

2026-07-01

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning communitY - Coordinating Center (KUH-FAMILY) (U24- Clinical Trials Not Allowed)

National Institutes of Health

The Division of Kidney, Urologic, and Hematologic Diseases (KUH) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) currently supports several institutional and individual training and career development programs. The purpose of this Notice of Funding Opportunity (NOFO) is to establish a single Coordinating Center to unite and harmonize these programs, which collectively aim to recruit, train, and retain an active, national community of researchers in KUH mission areas across career stages. This highly integrated community will be called KUH-FAMILY (Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning communitY).

2026-07-01

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning communitY - Coordinating Center (KUH-FAMILY) (U24- Clinical Trials Not Allowed)

National Institutes of Health

2026-07-01

Health

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kimberly Schaff Kiehl: Final Debarment Order

Health and Human Services Department

The Food and Drug Administration (FDA or the Agency) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Kimberly Schaff Kiehl for a period of 10 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Ms. Kiehl was convicted of two felonies under federal law. The factual basis supporting Ms. Kiehl's conviction, as described below, is conduct relating to the importation into the United States of a drug or controlled substance. Ms. Kiehl was given notice of the proposed debarment and was given an opportunity to request a hearing to show why she should not be debarred. As of March 9, 2026 (30 days after receipt of the notice), Ms. Kiehl had not responded. Ms. Kiehl's failure to respond and request a hearing constitutes a waiver of her right to a hearing concerning this matter.

See notice

Health

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kinase-Focused Target Identification and Structure Activity Relationship Exploration for a Novel Angelman Syndrome Therapeutic.

NINDS - National Institute of Neurological Disorders and Stroke

Summary Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by loss of the maternal UBE3A allele, leading to intellectual disability, ataxia, microcephaly, and seizures. Only maternal UBE3A is expressed in mature neurons, as the paternal transcript is silenced by a long noncoding antisense RNA (UBE3A-ATS). This unique biology offers an unprecedented therapeutic opportunity of restoring UBE3A expression by activating the intact but silenced paternal allele, an approach being vetted in clinical trials using antisense oligonucleotides (ASOs) to downregulate UBE3A-ATS and, hence, unsilence paternal UBE3A. Despite promising clinical data, ASOs face limitations including uneven biodistribution, risk of hydrocephaly, and invasive delivery. In contrast, blood brain barrier (BBB)-penetrant small molecules offer even brain biodistribution, reduced invasiveness, and greater patient accessibility. Our lab recently identified that the BBB- penetrant small molecule (S)-PHA533533 potently unsilences paternal UBE3A/Ube3a in AS patient-derived neurons and mouse primary neurons. (S)-PHA533533 was designed to be a cyclin-dependent kinase 2 and 5 (CDK2 and CDK5) inhibitor; however, these kinases are not responsible for the unsilencing mechanism of action (MoA). Here, I aim to identify the MoA by which (S)-PHA533533 unsilences paternal Ube3a, allowing rational drug design away from CDK inhibition and toward enhanced on-target potency, improving therapeutic index for pediatric administration and advancing clinical candidate selection. Toward this goal, my lab developed a novel dual Ube3a reporter mouse that harbors a targeted knock-in following Ube3a containing NanoLuciferase for high throughput screening and nuclear-tagged superfolder GFP that enables nuclear sorting and rapid biodistribution assessments. Using this mouse model, I will explore the mechanism by which (S)-PHA533533 unsilences paternal Ube3a and will profile the structure-activity relationship of (S)-PHA533533 analogs, synthesized by our medicinal chemist collaborators. I will investigate the MoA through targeted ASO knockdown of known chemical interactors, a CRISPR whole kinome knockout screen, and a kinase chemogenetic inhibitor small library screen. I also aim to identify chemical modifications of (S)-PHA533533 that increase its potency and decrease its cytotoxicity, hence maximizing its therapeutic index. These experiments hold promise to develop a first-in-class, brain penetrant small molecule therapy for AS, ultimately improving quality of life for affected individuals and their caretakers.

Up to $41K

2029-05-31

health research

Free to search & build · $99 one-time to unlock the application pack · No subscription

King Abdullah Foundation Interfaith Dialogue Grants

King Abdullah bin Abdulaziz International Centre for Interreligious and Intercultural Dialogue

Supports interfaith dialogue, conflict resolution, and coexistence programs promoting understanding between religious communities.

$10K – $200K

interfaith dialogueconflict resolutioncoexistence

Free to search & build · $99 one-time to unlock the application pack · No subscription

King Baudouin Foundation Grants

King Baudouin Foundation

One of Europe's largest foundations (200M+ USD/yr). Funds poverty reduction, health, civic engagement, and democracy.

$10K – $500K

povertyHealthdemocracy+2

Free to search & build · $99 one-time to unlock the application pack · No subscription

King County Best Starts for Kids Grants

King County Department of Community and Human Services

King County's Best Starts for Kids levy funds grants to nonprofits providing early childhood development, youth services, family strengthening, and behavioral health services across the Seattle metropolitan area.

$50K – $750K

youth_developmentHealthEquity & Access+1

Free to search & build · $99 one-time to unlock the application pack · No subscription

King Faisal Foundation Programs

King Faisal Foundation

Supports education, health, and culture across the Muslim world.

$50K – $500K

EducationHealthculture+1

Free to search & build · $99 one-time to unlock the application pack · No subscription

Kinship Navigator Programs: Evaluations

upcoming

Administration for Children and Families - ACYF/CB

Kinship Navigator Programs: Evaluations